Modulation of the Antitumor Activity of Metronomic Cyclophosphamide by the Angiogenesis Inhibitor Axitinib

Lignende værker

• Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib
  af: Ma, Jie, et al.
  Udgivet: (2009)
• Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8(+) T-cell responses and immune memory
  af: Wu, Junjie, et al.
  Udgivet: (2015)
• VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression
  af: Doloff, Joshua C., et al.
  Udgivet: (2012)
• Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts
  af: Doloff, Joshua C, et al.
  Udgivet: (2015)
• Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
  af: Chen, Chong-Sheng, et al.
  Udgivet: (2014)